Hsuan-Yu Peng

524 total citations
10 papers, 368 citations indexed

About

Hsuan-Yu Peng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hsuan-Yu Peng has authored 10 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Hsuan-Yu Peng's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (5 papers) and RNA modifications and cancer (3 papers). Hsuan-Yu Peng is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (5 papers) and RNA modifications and cancer (3 papers). Hsuan-Yu Peng collaborates with scholars based in Taiwan and Japan. Hsuan-Yu Peng's co-authors include Shine‐Gwo Shiah, Jenn-Ren Hsiao, Yuan-Ming Hsu, Jang‐Yang Chang, Wei‐Min Chang, Michael Hsiao, Yi‐Shing Shieh, Ching‐Chuan Kuo, Su‐Fang Lin and Horng‐Dar Wang and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Hsuan-Yu Peng

10 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hsuan-Yu Peng Taiwan	9	285	219	72	29	29	10	368
Yue‐Ju Li Taiwan	9	243 0.9×	174 0.8×	71 1.0×	21 0.7×	29 1.0×	11	326
Nilesh Gardi India	12	204 0.7×	103 0.5×	96 1.3×	32 1.1×	32 1.1×	28	329
Xiaojiao Ban China	6	329 1.2×	209 1.0×	70 1.0×	31 1.1×	19 0.7×	8	412
Giórgia Gobbi da Silveira Brazil	9	182 0.6×	84 0.4×	161 2.2×	39 1.3×	33 1.1×	12	334
Zhen‐Ming Xu China	13	321 1.1×	187 0.9×	54 0.8×	27 0.9×	23 0.8×	25	388
Koji Katada Japan	7	308 1.1×	240 1.1×	39 0.5×	37 1.3×	19 0.7×	7	386
Franziska Niehr Germany	8	175 0.6×	77 0.4×	136 1.9×	56 1.9×	17 0.6×	10	276
Rongxia Liao China	10	292 1.0×	245 1.1×	118 1.6×	28 1.0×	32 1.1×	18	429
Rachel Zangen United States	5	251 0.9×	65 0.3×	212 2.9×	19 0.7×	11 0.4×	7	349
Justin Bishop United States	7	167 0.6×	83 0.4×	87 1.2×	72 2.5×	23 0.8×	9	258

Countries citing papers authored by Hsuan-Yu Peng

Since Specialization

Citations

This map shows the geographic impact of Hsuan-Yu Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsuan-Yu Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsuan-Yu Peng more than expected).

Fields of papers citing papers by Hsuan-Yu Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsuan-Yu Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsuan-Yu Peng. The network helps show where Hsuan-Yu Peng may publish in the future.

Co-authorship network of co-authors of Hsuan-Yu Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Hsuan-Yu Peng. A scholar is included among the top collaborators of Hsuan-Yu Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsuan-Yu Peng. Hsuan-Yu Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Peng, Hsuan-Yu, Lijie Li, Bou‐Yue Peng, et al.. (2025). The miR-876-5p/SOCS4/STAT3 pathway induced the expression of PD-L1 and suppressed antitumor immune responses. Cancer Cell International. 25(1). 114–114. 1 indexed citations

Peng, Hsuan-Yu, et al.. (2020). MiR-944/CISH mediated inflammation via STAT3 is involved in oral cancer malignance by cigarette smoking. Neoplasia. 22(11). 554–565. 33 indexed citations

Shiah, Shine‐Gwo, Jenn-Ren Hsiao, Yuan-Ming Hsu, et al.. (2020). MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer. Journal of Biomedical Science. 27(1). 46–46. 57 indexed citations

Peng, Hsuan-Yu, Yuan-Ming Hsu, Jenn-Ren Hsiao, et al.. (2019). MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1. Journal of Experimental & Clinical Cancer Research. 38(1). 281–281. 63 indexed citations

Shiah, Shine‐Gwo, Hsuan-Yu Peng, Ya‐Wen Chen, et al.. (2019). TNF-α-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility. PLoS ONE. 14(3). e0213463–e0213463. 30 indexed citations

Peng, Hsuan-Yu, et al.. (2018). Thrombospondin-2 is a Highly Specific Diagnostic Marker and is Associated with Prognosis in Pancreatic Cancer. Annals of Surgical Oncology. 26(3). 807–814. 21 indexed citations

Chang, Wei‐Min, Yuan‐Feng Lin, Chia‐Yi Su, et al.. (2017). Parathyroid Hormone-Like Hormone is a Poor Prognosis Marker of Head and Neck Cancer and Promotes Cell Growth via RUNX2 Regulation. Scientific Reports. 7(1). 41131–41131. 36 indexed citations

Chang, Wei‐Min, Yuan‐Feng Lin, Chia‐Yi Su, et al.. (2016). Dysregulation of RUNX2/Activin-A Axis upon miR-376c Downregulation Promotes Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma. Cancer Research. 76(24). 7140–7150. 41 indexed citations

Peng, Hsuan-Yu, Jenn-Ren Hsiao, Michael Hsiao, et al.. (2016). IL‐8 induces miR‐424‐5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma. Molecular Oncology. 10(6). 895–909. 58 indexed citations

10.

Peng, Hsuan-Yu, Yuan-Ming Hsu, Ching‐Chuan Kuo, et al.. (2016). MPT0B098, a Microtubule Inhibitor, Suppresses JAK2/STAT3 Signaling Pathway through Modulation of SOCS3 Stability in Oral Squamous Cell Carcinoma. PLoS ONE. 11(7). e0158440–e0158440. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact